Precision BioSciences
DTIL
116 hedge funds and large institutions have $156M invested in Precision BioSciences in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 17 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 23
79% more call options, than puts
Call options by funds: $334K | Put options by funds: $187K
6% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 17
1% more funds holding
Funds holding: 115 → 116 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less ownership
Funds ownership: 1.63% → 1.63% (-0%)
26% less capital invested
Capital invested by funds: $211M → $156M (-$54.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.99M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.05M |
| 3 |
IHAM
Integral Health Asset Management
New York
|
+$1.99M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.69M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.38M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VP
venBio Partners
San Francisco,
California
|
-$9.9M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$8.52M |
| 3 |
Millennium Management
New York
|
-$3.67M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$1.63M |
| 5 |
ACWM
Adams Chetwood Wealth Management
Durham,
North Carolina
|
-$1.33M |
DTIL Hedge Fund Activity: Q3 2020 in Review
116 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2020, worth a combined $156M — down 26% from $211M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new DTIL positions and 17 closed out — a net gain of 1 holder — while 42 added to existing stakes and 23 trimmed.
The largest buyer was BlackRock, adding an estimated $3.99M. The largest seller was venBio Partners, cutting an estimated $9.9M.
- 116 institutional investors held Precision BioSciences (DTIL) as of Q3 2020, up from 115 in Q2 2020.
- Funds reported $156M of Precision BioSciences stock for Q3 2020, down 26% quarter-over-quarter.
- 18 funds opened new Precision BioSciences positions in Q3 2020 and 17 closed out, a net change of +1 holder.
- The largest Precision BioSciences buyer in Q3 2020 was BlackRock, an estimated $3.99M added.
- The largest Precision BioSciences seller in Q3 2020 was venBio Partners, an estimated $9.9M sold.
Based on aggregated 13F filings for Q3 2020.